Starpharma Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPHRF research report →
About the company
Starpharma Holdings Limited is a global biopharmaceutical firm dedicated to the investigation, advancement, and marketing of its proprietary dendrimer-based products for pharmaceutical, life science, and other diverse applications. Among its commercialized offerings is VivaGel, an antibiotic-free therapy designed for both preventing and managing bacterial vaginosis. The company's pipeline also features the VivaGel antiviral condom and VIRALEZE, an antiviral nasal spray.
- CEO
- Cheryl Maley
- IPO
- 2007
- Employees
- 40
- HQ
- Abbotsford, VIC, AU
Price Chart
- Market Cap
- $218.88M
- P/E
- -95.45
- P/S
- 21.70
- P/B
- 14.33
- EV/EBITDA
- -36.48
- Div Yield
- 0.00%
- Gross Margin
- 60.11%
- Op Margin
- -100.14%
- Net Margin
- -22.67%
- ROE
- -15.96%
- ROIC
- -11.57%
- Revenue
- $4.91M · -40.74%
- Net Income
- $-9,990,000 · -22.35%
- EPS
- $-0.02 · -19.50%
- Op Income
- $-11,998,000
- FCF YoY
- 3.75%
- 52W High
- $0.58
- 52W Low
- $0.06
- 50D MA
- $0.47
- 200D MA
- $0.31
- Beta
- 0.77
- Avg Volume
- 5.90K
Get TickerSpark's AI analysis on SPHRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SPHRF coverage
Recent articles, reports, and earnings notes.
No research on SPHRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPHRF report →Similar companies
Peers in the same neighborhood.